ArticleBritish journal of haematology2020

A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients.

Phuong Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.